(1/2) EAS Consensus Panel latest! We are glad to inform you that our Updated EAS statement on homozygous familial hypercholesterolaemia: driving better care of patients globally has been just published. It’s available in Open Access. https://t.co/p8jJ6Jf9tq
A new polygenic score built using massive, diverse datasets and multiple related traits significantly improves the accuracy of genetic risk prediction of heart disease across all ancestries. https://t.co/XwfhvUT7c3
Terrific summary of our recent paper describing an enhanced polygenic score for coronary artery disease:
https://t.co/sAv9EbVvEm
Paper (open-access): https://t.co/hgKmnJy1w7
🔥AGA clinical practice: #Bloating & Distention
The 6 "R"s of Bloating 🎈
Rule out constipation
Rule out food causes: Intolerance/gluten/allergy
Rule out organic causes
Rule out motility causes
Rule out SIBO
Rx for APD or hypersensitivity
#GITwitter#DGBI#MedTwitter
Reviewing CKD KDIGO 2023
1-CKD definition
G1 and G2 are not “CKD” unless evidence of kidney damage is proved (then, urinary analysis and US is needed?)👇🏼👇🏼b
The #Mediterranean diet outranked 6 other popular diets in reducing heart attack, stroke, and all-cause mortality in a recent study.
Dietary counseling should be part of every care plan in those at high risk for #cardiovascular disease
5438 patients on DAPT for 12±6 mon post PCI—> randomized in a 1:1 ratio to receive clopidogrel (75 mg daily) or aspirin (100 mg daily)—>F/up of >5 y —>clopidogrel monotherapy was associated with lower rates of the composite net clinical outcome. #Cardiotwitter#MedEd#MedTwitter
TLDR is a newsletter for people who work in tech, programming, and science.
No politics or sports. Just the most captivating headlines in tech that we can all geek out on.
We summarize the most interesting stories, so you can stay up to date in less than 5 minutes a day.
【New Approaches to Chronic Hepatitis B】NEJM Jan 2023
👉An estimated 296 million people have chronic hepatitis B
👉221 million live in low- and middle-income countries
👉Without intervention, deaths from HBV are expected to peak at 1.14 million by 2035
https://t.co/Q5FCmu6IaH
BREAKING: It's happening. An original animated series following the next earth Avatar in the cycle after Aang and Korra is coming in 2025 from Paramount and Avatar Studios.
All the info: https://t.co/szlm5I13TM
Join us on Tuesday, December 13th, 3 p.m. EDT for the final installment of the "Hands On: Tips to Improve Diabetes Care" webinar series: a live, highly interactive session to review the top 30 diabetes care tips that your care team should know. Register at https://t.co/iiBr6Jp37h
Love this piece on GDMT uptitration!
(Also totally a great example to remind your teams that initiation of quadruple therapy is recommended as a first step, so at the very least let's start that spironolactone today, plz and thx)
https://t.co/ymd6YtBW7W
The ADA published the 2023 update to the Standards of Care in Diabetes, the standard for #diabetes care. 🩺 Access the Standards NOW: https://t.co/xhB0Pux4Qc. 📚
It’s officially out 📣📣📣📣
ADA standards of care 2023
Privileged and honored to lead this effort with an outstanding , talented and dedicated team from @AmDiabetesAssn and members of our Professional Practice Committee @ADA_DiabetesPro@DrBobGabbay 👉🏼https://t.co/hjnqUj4l8n
NNT to prevent 1 death from any cause
Aspirin for secondary prevention: 333
Spironolactone for HFrEF: 9
If discharging a CAD patient without aspirin sounds crazy, then what does that say about discharging a HFrEF patient without an MRA?
BREAKING NEWS: New #Alzheimer drug #Lecanemab slows cognitive decline (18-month change in CDR-SB) by 27%, drastically lowers brain amyloid load by 59 centiloids to 23 (below PET amyloid positivity)! NEJM paper: https://t.co/XYaxRlkH48 https://t.co/29YFLvyS8t #CTAD